In particular, we highlight the eminent role of the osteoprotegerin (OPG)-receptor activator of nuclear factor-κB (RANK)-RANK ligand (RANKL) system in the development of CN. The gene discussed is TNFSF11; the disease is cyclic hematopoiesis.